Arkolith/Insider Trading/AEON/Form 4

Wilson Alexander Blair

EXEC VP, CLO & CORP SECRETARYAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Sep 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 31, 2024Grant(A)180K—$0262K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 31, 2024Grant(A)481K—$0481K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-097066) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML